1. Home
  2. CSTL vs COUR Comparison

CSTL vs COUR Comparison

Compare CSTL & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.51

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$6.04

Market Cap

932.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
COUR
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
806.3M
932.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CSTL
COUR
Price
$24.51
$6.04
Analyst Decision
Strong Buy
Buy
Analyst Count
6
14
Target Price
$47.17
$11.07
AVG Volume (30 Days)
261.5K
3.8M
Earning Date
05-04-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.22
EPS
N/A
N/A
Revenue
$344,229,000.00
$757,500,000.00
Revenue This Year
$2.42
$9.43
Revenue Next Year
$12.69
$6.40
P/E Ratio
N/A
N/A
Revenue Growth
3.66
9.04
52 Week Low
$14.59
$5.22
52 Week High
$44.28
$13.56

Technical Indicators

Market Signals
Indicator
CSTL
COUR
Relative Strength Index (RSI) 44.61 52.96
Support Level $21.77 $5.48
Resistance Level $26.44 $6.36
Average True Range (ATR) 1.14 0.33
MACD 0.24 0.02
Stochastic Oscillator 61.15 69.47

Price Performance

Historical Comparison
CSTL
COUR

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: